Paternal valproate exposure and child neurodevelopment: What this Taiwan study found
This nationwide Taiwan study included 2,583,503 people born from 2001 through 2016 and followed through 2021.
-
-
Devices & Neuromodulation | Drug-Resistant Epilepsy | Epilepsy Research Summaries | Genetics | New Studies | Pediatrics
Epilepsy Surgery Referral: Why Evaluation Remains Underused
This article was a critical review, not a new clinical trial, and the abstract does not report enrolling participants.
-
Drug-Resistant Epilepsy | Epilepsy Research Summaries | Genetics | Imaging & EEG | New Studies | Pediatrics
Early Infantile Encephalopathy: Diagnosis, Outcomes, and Treatment Research
This narrative review brought together published research on early infantile developmental and epileptic encephalopathy (EIDEE), a severe epilepsy syndrome beginning before 3 months of age.
-
Drug-Resistant Epilepsy | Epilepsy Research Summaries | Genetics | Ketogenic Diet | New Studies | Pediatrics
EIMFS Genetic Testing and Treatment: What the Review Found
This scoping review mapped published research on epilepsy of infancy with migrating focal seizures (EIMFS), a rare and severe epilepsy syndrome beginning in infancy.
-
Neurocysticercosis and Seizures in South-East Asia: What the Review Found
Researchers combined 50 observational studies involving 10,743 people who presented with seizures in South-East Asia.
-
Epilepsy and Menopause: What the Review Says About Treatment and Seizures
This was a narrative review of existing information about epilepsy during perimenopause and menopause.
-
Levetiracetam Versus Sodium Valproate in Children: Evidence Review
This systematic review and meta-analysis compared levetiracetam with sodium valproate in children age 18 or younger with new-onset epilepsy or established status epilepticus.
-
Seizure Recurrence After Withdrawal in Children With Epilepsy
Researchers combined results from 19 studies involving 3,226 children with epilepsy.
-
Epilepsy Comorbidities in Children: What a Norwegian Study Found
Researchers described co-occurring health conditions in 1,054 children and youth with validated epilepsy diagnoses in Norway.
